Skip to content

Price / sales at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
6.1×+1.6×
Stryker logo
StrykerSYK
-1.1×
CONMED logo
CONMEDCNMD
0.8×-0.6×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
2.1×-0.8×
Enovis logo
EnovisENOV
0.6×-0.4×
OrthoPediatrics logo
OrthoPediatricsKIDS
1.6×-1.2×

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-26.6%
Enterprise value$320.25M-22.6%

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Calculated from Treace Medical Concepts, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s price / sales?
Treace Medical Concepts, Inc. (TMCI) reported price / sales of 0.4× in Q1 2026.
How has Treace Medical Concepts, Inc.'s price / sales changed year-over-year?
Treace Medical Concepts, Inc.'s price / sales decreased by 83.2% year-over-year, from 2.5× to 0.4×.
What is the long-term trend for Treace Medical Concepts, Inc.'s price / sales?
Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s price / sales has grown at a -49.0% compound annual growth rate (CAGR), from 10.8× to 0.7×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.